immunoreactivity with the anti-keratin monoclonal antibodies ae1 and ae3 was demonstrated in 24 cases ( 80 % ) including 4 of 6 ( 66 % ) well-differentiated astrocytomas ( wdas ) , 10 of 12 ( 83 % ) anaplastic astrocytomas ( anas ) , and 10 of 12 ( 83 % ) glioblastomas multiforme ( gbms ) .
C0004114
astrocytomas
C0017636
glioblastomas multiforme